Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

(R,S)-N-Nitrosoanatabine

    • Product Name (R,S)-N-Nitrosoanatabine
    • Alias NNN
    • Einecs 699-410-2
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    545601

    Compound Name (R,S)-N-Nitrosoanatabine
    Molecular Formula C10H14N3O
    Molecular Weight 192.24 g/mol
    Cas Number 22267-91-0
    Iupac Name 1-nitroso-3-(3-pyridyl)piperidine
    Appearance Solid
    Solubility Soluble in organic solvents
    Chemical Class Nitrosamine alkaloid
    Smiles CN1CCCC(C1)C2=CN=CC=C2N=O
    Pubchem Cid 68295
    Chirality R,S (racemic mixture)
    Hazard Classification Potential carcinogen
    Origin Derived from tobacco alkaloid anatabine

    As an accredited (R,S)-N-Nitrosoanatabine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing Amber glass bottle containing 1 gram of (R,S)-N-Nitrosoanatabine, tightly sealed with a tamper-evident cap and hazard label.
    Shipping (R,S)-N-Nitrosoanatabine is shipped in securely sealed containers under ambient or refrigerated conditions, compliant with all relevant chemical transport regulations. Packaging ensures protection from moisture, light, and contamination. All shipments include proper labeling, safety documentation, and hazard precautions to guarantee safe handling and regulatory compliance during transit.
    Storage (R,S)-N-Nitrosoanatabine should be stored in a tightly closed container under cool, dry, and well-ventilated conditions, away from light and incompatible materials such as strong oxidizers. It must be kept at 2–8°C (refrigerated) to minimize decomposition and nitrosamine formation. Handle with care, as it is potentially carcinogenic; appropriate safety precautions and personal protective equipment are required.
    Application of (R,S)-N-Nitrosoanatabine

    Applications of (R,S)-N-Nitrosoanatabine in Industrial Manufacturing

    (R,S)-N-Nitrosoanatabine is a specialty intermediate primarily supporting the pharmaceutical, nicotine research, laboratory reagent, and tobacco reference material sectors. As the actual manufacturer, we observe strict quality, regulatory, and process integration requirements in every downstream channel. Each application relies on its unique formulation demands, integration procedures, and compliance regimes.

    1. Reference Standards for Analytical Laboratories

    Accredited testing laboratories and universities commonly use (R,S)-N-Nitrosoanatabine as a certified reference material to calibrate analytical instruments in nicotine exposure and nitrosamine compound analysis. Labs integrate this intermediate with sample preparation workflows for quantification, validation, and method development, especially in studies measuring trace nitrosamines in tobacco products and biological matrices. Fine control of purity is essential to minimize analytical background noise and ensure reliable trace-level detection, meeting exacting quality requirements from regulatory frameworks governing test accuracy.

    Industry compliance standards

    • ISO/IEC 17025 (General requirements for the competence of testing and calibration laboratories)
    • ASTM D4765 (Standard Test Method for Determination of Nitrosamines)
    • FDA Guidance for Industry: Control of Nitrosamine Impurities
    • USP General Chapter <1226> (Verification of Compendial Procedures)

    Typical usage ratio

    • 0.01–10 ppm as spike; actual use depends on calibration curve range and detection limits for the analytical platform

    Downstream process integration

    • Dissolve in analytical-grade solvent; add to quality control, proficiency testing, or method validation batches during sample preparation prior to LC-MS, GC-MS, or HPLC runs

    Final product types

    • Certified reference standards
    • Proficiency test samples
    • Calibration solutions for analytical equipment
    • Trace nitrosamine quantification kits

    2. Synthesis of Nitrosamine Impurity Markers for Pharmaceutical Development

    Pharmaceutical R&D and QC teams use (R,S)-N-Nitrosoanatabine for internal impurity marker synthesis during new small molecule drug development. Our high-purity material serves as a controlled intermediate for nitrosamine risk assessment, allowing detection and quantification in API and drug product process streams. Formulators, regulatory affairs, and QA/QC personnel work together to ensure that all process steps using this chemical meet global nitrosamine impurity standards.

    Industry compliance standards

    • ICH M7 (Assessment and Control of DNA Reactive (Mutagenic) Impurities in Pharmaceuticals)
    • EU GMP Annex 1/21 CFR Part 211 (Good Manufacturing Practice for Finished Pharmaceuticals)
    • USP General Chapter <1469> (Nitrosamine Impurities)

    Typical usage ratio

    • 0.005–0.1% (w/w) in intermediate control samples or as spike in process validation; varies with method detection sensitivity and batch size

    Downstream process integration

    • Introduce to API or excipient matrices in laboratory scale to simulate or test for production impurities and validate cleaning or mitigation strategies

    Final product types

    • Nitrosamine impurity standards for pharmaceuticals
    • Regulatory submission data packages (impurity risk analysis)
    • Validated lab-scale API samples
    • Research reference lots for process development

    3. Tobacco Industry: Reference Substance for Quality Control and Research

    Major tobacco product manufacturers, contract research labs, and regulatory compliance entities procure (R,S)-N-Nitrosoanatabine as a quantitative standard for monitoring trace-level nitrosamines in cigarette, cigar, and smokeless tobacco matrices. Quality assurance staff integrate this compound into internal and external laboratory testing, compliance protocols, and new product research. Meeting applicable ISO and government standards in each market is non-negotiable, with routine updates required as global nitrosamine reporting thresholds evolve.

    Industry compliance standards

    • ISO 17034 (General requirements for the competence of reference material producers)
    • CORESTA CRM 70 (Standard Methods for the Determination of Tobacco-specific Nitrosamines)
    • US FDA Tobacco Control Act compliance (21 CFR Parts 1100, 1140, and 1143)

    Typical usage ratio

    • 1–50 ng/g in tobacco matrix; actual spike selected based on instrument calibration and the expected concentration range in regulatory submissions

    Downstream process integration

    • Add to sample extraction stages before chromatography analysis for quantitation of nitrosamine contamination in raw, cured, or final tobacco products

    Final product types

    • Standardized tobacco reference materials
    • Quality control sample sets for manufacturing lots
    • Validated compliance files for regulatory agencies
    • Materials for method transfer between factory and third-party labs

    4. Research Reagent in Chemical Carcinogenesis Studies

    University research groups and toxicology institutes utilize (R,S)-N-Nitrosoanatabine in chemical carcinogenesis trials to model and investigate nitrosamine metabolic pathways. Specialist technicians handle the compound according to institutional biosafety protocols. Precision dosing, controlled storage, and consistent batch-to-batch composition are critical to produce reproducible experimental data for publications, grant reporting, and governmental advisory studies.

    Industry compliance standards

    • OECD Guidelines for the Testing of Chemicals (Section 4: Health Effects)
    • GLP (Good Laboratory Practice) per OECD and US EPA 40 CFR Part 160
    • IACUC-approved animal use protocols where in vivo models are employed

    Typical usage ratio

    • 5–200 μg/kg in biological model doses; adjusted based on species, study objective, and ethical review panel stipulations

    Downstream process integration

    • Dilute to working solution prior to cell-based or animal-based administration; track via electronic laboratory notebooks for dose verification in experimental setup

    Final product types

    • In vitro and in vivo toxicology data sets
    • Mechanistic studies on nitrosamine metabolism
    • Peer-reviewed scientific publications
    • Grant submission supporting materials
    Free Quote

    Competitive (R,S)-N-Nitrosoanatabine prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    (R,S)-N-Nitrosoanatabine: Manufacturer’s Perspective on Production, Quality, and Use

    (R,S)-N-Nitrosoanatabine draws a lot of interest, especially in fields focused on alkaloid derivatives and analytical reference standards. As the original manufacturer, we approach every batch as a unique product, not just another chemical on a shelf. This compound belongs to the nitrosamine class, so working with it brings special challenges and responsibilities. Our direct involvement in each step, from synthesis to purification, shapes the consistency and trustworthiness that researchers come to expect in sensitive analytical projects.

    Model, Specifications, and Manufacturing Control

    We produce (R,S)-N-Nitrosoanatabine using precision-controlled small-batch synthesis. The process relies on high-purity precursors and tight environmental controls, because contamination or unwanted isomer formation affects analytical output and downstream applications. We engage in repetitive batch monitoring from first reaction to final drying. With nitrogenous alkaloids, trace water content or slight excesses in reagents can trigger byproducts, so we always run real-time checks using HPLC and mass spectrometry. Our internal specifications focus above all on racemic purity, absolute structure validation via NMR, and very low residual solvent content.

    Most requests fall within standard ranges as far as chemical form—offering (R,S)-N-Nitrosoanatabine as a crystalline or amorphous solid based on project needs. Both forms appear pale yellow to light brown, reflecting subtle batch-to-batch differences, as full elimination of coloration without affecting integrity remains impractical in the real world. The melting point, specific rotation, and IR profile establish compound identity beside purity reports, all measured in our production lab for every delivery.

    From Lab Interest to Production Highlights

    Not every compound commands the same production attention as (R,S)-N-Nitrosoanatabine. Demand often rises from research on tobacco alkaloid metabolism and carcinogen screening. Nitrosation of alkaloids like anatabine serves as a model for studying nitrosamines in human toxicology, but only clean, well-characterized compounds produce reliable results. Academic groups and pharmaceutical companies approach us for supply because most distributors cannot trace the source or guarantee the absence of cross-contaminants that might impact assays.

    Our chemists work on-site with each order, so when a request mentions a specific isomer or analytical feature—such as maximizing (R,S) ratio control—we adjust protocols directly rather than simply shipping out from generic stock. Everyday handling includes rigorous self-imposed restrictions on humidity, oxygen ingress, and UV light exposure, which all accelerate decomposition or unintended nitrosation side-reactions in these molecules. Anyone familiar with nitrosamine research will recognize how small variations at scale quickly alter experimental data.

    Practical Use and Application Insights

    Most of the time, (R,S)-N-Nitrosoanatabine ends up in the hands of chemical analysts, toxicologists, and tobacco research groups. These teams use it as a reference standard for chromatographic methods or as a model compound in cell exposure studies. Other lot sizes support method validation for detecting nitrosamines in food, pharmaceuticals, and environmental samples. In our experience, consistency matters most: reproducibility in LC–MS, GC–MS, or UV detection depends on eliminating invisible variances in the standard.

    We also receive feedback from clients who face troubleshooting needs mid-project. A researcher might observe baseline disturbances during mass spec runs, only to find that their commercial standard wasn’t truly free from alt-nitrosamines created as trace byproducts during contract manufacturing. Synthetizing the substance in-house, we maintain full oversight on every solvent and reagent used, with result documents that provide all analytical traces, not just a summary page. This approach connects our production floor directly to your laboratory notebook—no black boxes, no blanks to fill.

    Another point of differentiation involves flexible lot sizing. Contract research organizations and industry testing labs rarely have identical volume requirements; some need 10 mg for a pilot, others 1 gram or more for extended stability studies. As manufacturers, we find it easier to customize lot sizes and labelling, so each customer receives product handled and packaged for the specific project, minimizing losses and cost inefficiencies. Bulk batches retain the original production records, so traceability never breaks down, even if requests go through several years.

    Differences From Distributor or Trader-Sourced Materials

    Distributors and third-party suppliers often move chemicals under the same labeling, but without direct production knowledge, they can’t guarantee process details, side-product profiles, or storage standards. We’ve seen too many situations in which nitrosamine standards sourced from unknown hands come with generic documentation. Such approaches suit purely qualitative research, but not quantitative or regulatory workflows.

    Direct-from-manufacturer sourcing also lets clients raise technical questions that we answer ourselves. If an end-user encounters unexpected impurities or an isomer ratio that drifts with time, our production and quality control notes map every deviation or question back to the date of manufacture. Certificates of analysis from us present spectra and trace-level impurity profiles, not just high-level purity numbers, revealing everything seen from NMR, GC, LC–MS, and moisture checks. Even for our regular customers, we’ve occasionally compared samples sent by other labs—it’s striking how much difference direct control of inputs and process brings.

    Storage and transport matter for nitrosamines. We provide guidance—drawn from direct compound stability runs—on handling, transport, and shelf-life, rather than simply copying general expectations. This knowledge comes from practical experience: nitrosamines don’t tolerate heat or light, and their degradation products complicate trace quantitation. We instruct users to keep each vial protected from strong light and under inert gas to maximize lifetime. These insights arise only through daily interaction with the chemical's behavior during real-world storage and shipment.

    Quality Questions: Analytical Validation and Regulatory Expectations

    Researchers in regulated environments, pharmaceuticals, or food safety projects demand more than a label; they want chain-of-custody detail throughout the process. As the manufacturer, we furnish original analytical data connecting source materials, reaction details, and finished batch analysis. We retain multiple batches over time for cross-reference and stability checks, supporting client audits and retrospective validations.

    The regulatory climate now treats nitrosamines with close scrutiny, especially with recent discoveries of genotoxic impurities in several drug products. We’ve seen additional documentation requests from pharmaceutical clients, including detailed impurity profiles, gas analysis for volatile reclamation, and reference to in-house validated analytical methods. These requirements put extra demands on us—but also clarify that full supply chain transparency and manufacturer provenance establish the difference between pass and fail under audit.

    On rare occasions, a client may approach us about impurities above expected thresholds or stability issues with long-term refrigerated storage. We collaborate to pinpoint the root cause, as we track every batch component and process change over the years. In a few instances, observations from a high-sensitivity detector prompted us to re-examine older purification steps, leading to procedural tweaks to improve next-generation lots. Our approach improves with each round of feedback, ensuring applied science shapes tomorrow’s production, not just yesterday’s standards.

    Handling, Storage, and Safety Lessons Learned

    We monitor International Agency for Research on Cancer notes and regulatory intelligence to stay abreast of new guidance on nitrosamines. Handling such materials in an industrial setting needs tailored protocol—minimizing exposure, running routine surface and air tests, and maintaining airtight containment wherever possible. We require standard PPE for all staff and undergo routine environmental monitoring; our lab directly benefits, since any breach shows up in QA/QC checks before shipping out.

    Temperature and humidity remain the main variables affecting final product lifetime. We never ignore seasonal shifts that influence solvent evaporation rates, reagent purity, or ambient humidity. Experience has shown that excess heat speeds up decomposition, particularly if nitrogen tanks draw down below specification, so we stick with validated temperature-and-moisture controls around all stored and working materials. Users downstream reap the benefits as their product matches our original analytical profile even months into storage.

    Training our team to recognize changes in odor, color, or texture of nitrosamine intermediates keeps us ahead of issues. Often, subtle changes precede analytical drift or final product setbacks, but a practiced eye catches them before they impact delivery. Feedback from customers sometimes circles back into our training notes, building a feedback loop from lab bench to the manufacturing bay.

    Ordering and Traceability: Advantages From Manufacturing Source

    Working directly with researchers and analysts allows us to match their intended test plans on lot size, grade, and documentation. If someone needs extra test data, copies of original spectra, or guidance on dilution protocols, we tap internal records and experience to answer, instead of waiting for a supplier to chase down an original batch file. Specific documentation—like a full trace of water and heavy metal checks, or an auxiliary NMR spectrum—proves critical for regulated work, and we make them available with every lot.

    Product recalls or repeat orders rely on batch records dating back years, which we maintain in digital and physical archives. Industry compliance rests on the ability to connect a current sample back to its original synthesis route, precursor lot, and QC cycle. This level of traceability stands as a practical difference between working with a manufacturer and a supply aggregator—our direct connection builds confidence that spans compliance, reproducibility, and safety.

    Comparing to Other Nitrosamine Standards and Isomers

    The (R,S) isomer ratio stands out in comparison to other reference nitrosamines. It bridges analytical flexibility—supporting method calibration for both enantiomers—whereas pure (R)- or (S)-isomers may serve niche projects less often. Most public datasets, including those for regulatory thresholds, use racemic (R,S)-N-Nitrosoanatabine because it matches environmental and bodily exposures more closely. At the same time, our plant handles single-isomer derivatives alongside mixtures, so if a client’s work calls for differentiated separation, we support decisions on reference selection and method development.

    Impurity profiles separate us from catalog sources. Our facility can identify and quantify specific byproducts, including minor anatabine derivatives or associated nitrosamines, which improves user confidence. Independent labs sometimes compare our standards to those of unknown origin, and minor kinks in chromatograms always trace back to inconsistencies in outsourced material.

    Critically, our entire approach produces batch-dependent supporting data: full certificates featuring each parameter we measure and compare, not only to internal thresholds but against customer requests. No two users need the same documentation or form—one may need xylenes removed to sub-ppm, another focuses on trace water. We can accommodate or explain, pulling from firsthand records at every step.

    Practical Solutions and Ongoing Challenges

    Experience reveals several lasting challenges for manufacturing (R,S)-N-Nitrosoanatabine: scaling up without risking batch variability, ensuring airtight quality assurance during shipment, and responding to shifting regulatory priorities. Our solutions grow out of years of hands-on production. We routinely invest in new solvent handling, dry room technology, and analytical upgrades. Digital record-keeping underpins our shipping and batch tracking—every bottle, every gram stays mapped to its original entry in our system.

    We continually update procedures in response to user feedback, regulatory revisions, and advances in analytical science. For example, as lower toxicity thresholds for nitrosamines appear in pharmaceutical guidance globally, we refine our impurity checks and invest more in high-sensitivity analytical reference standards. This helps researchers and clients stay compliant and at the cutting edge without worrying about supply chain weak points.

    At the end of the day, (R,S)-N-Nitrosoanatabine draws significance from daily, direct engagement with its chemistry, not just abstract protocols. Each batch connects manufacturing skill, quality management, and customer feedback in a loop that distinguishes real, proven material from generic supply. As scientific and regulatory needs evolve, maintaining this hands-on, traceable connection defines the future of specialty chemical manufacturing—including every molecule and every customer relationship.